Announcements - Search results

Search results: Company announcements for
ONCOSIL MEDICAL LTD (OSL)
Released between 01/01/2020 and 31/12/2020

Didn't find the announcement you were after? Search again.

Announcements released as OSL
Date Price sens. Headline
18/09/2020
4:20 PM
  2020 Notice of General Meeting & Proxy Form
30 pages 1.0MB
28/08/2020
11:24 AM
asterix Investor Update
19 pages 1.3MB
28/08/2020
11:23 AM
  Investor Update - Conference Call Notification
2 pages 214.7KB
28/08/2020
8:17 AM
asterix OncoSil receives Malaysian regulatory approval
2 pages 253.3KB
19/08/2020
7:24 PM
  Appendix 4G and Corporate Governance Statement
17 pages 317.3KB
19/08/2020
7:23 PM
asterix Preliminary Final Report - Appendix 4E Announcement
3 pages 285.4KB
19/08/2020
7:22 PM
asterix Appendix 4E and Annual Report
68 pages 3.2MB
07/08/2020
5:01 PM
  Clarification of June Quarter Appendix 4C
1 page 145.0KB
30/07/2020
8:33 AM
asterix Appendix 4C - quarterly
9 pages 487.0KB
28/07/2020
8:22 AM
asterix HDE filing submitted in US for Bile Duct Cancer treatment
2 pages 215.4KB
03/07/2020
9:45 AM
asterix OncoSil presents clinical data at ESMO World Congress
4 pages 515.5KB
02/07/2020
9:06 AM
asterix OncoSil files for TGA registration
2 pages 219.6KB
30/06/2020
4:46 PM
  Change of Director's Interest Notice
2 pages 126.5KB
30/06/2020
4:46 PM
  Change of Director's Interest Notice
2 pages 238.8KB
30/06/2020
4:37 PM
  Cancellation of shares under the Employee Share Plan
4 pages 209.7KB
01/06/2020
8:42 AM
asterix OncoSil receives Singapore regulatory approval
2 pages 264.4KB
29/05/2020
6:19 PM
  Change of Directors Interest Notice
2 pages 238.6KB
29/05/2020
6:17 PM
  Change of Director's Interest Notice - Roger Aston
2 pages 238.6KB
29/05/2020
6:02 PM
  Change of Director's Interest Notice - Michael Bassett
2 pages 239.4KB
29/05/2020
6:01 PM
  Change of Director's Interest Notice - Martin Cross
2 pages 238.5KB
29/05/2020
6:01 PM
  Change in substantial holding - Daniel Kenny
2 pages 238.6KB
29/05/2020
6:01 PM
  Change of Director's Interest Notice - Chris Roberts
2 pages 241.0KB
29/05/2020
6:01 PM
  Appendix 3Y - Late Lodgement Notice - Roger Aston
4 pages 585.1KB
29/05/2020
6:01 PM
  Appendix 3Y - Late Lodgement Notice - Daniel Kenny
4 pages 405.0KB
28/05/2020
10:17 AM
  Appendix 2A
14 pages 275.5KB
26/05/2020
6:40 PM
  Ceasing to be a substantial holder
7 pages 46.0KB
26/05/2020
9:20 AM
asterix Entitlement Offer Results and Shortfall Notification
2 pages 222.1KB
19/05/2020
4:56 PM
  Ceasing to be a substantial holder
1 page 581.4KB
13/05/2020
1:56 PM
  Becoming a substantial holder
7 pages 343.0KB
12/05/2020
5:17 PM
  Becoming a substantial holder
2 pages 83.2KB
12/05/2020
9:20 AM
asterix OncoSil Entitlement Offer Booklet
27 pages 479.1KB
08/05/2020
6:22 PM
  Ceasing to be a substantial holder
8 pages 328.6KB
08/05/2020
9:26 AM
  Appendix 2A
14 pages 173.8KB
08/05/2020
9:25 AM
  Cleansing Notice
1 page 76.2KB
08/05/2020
9:24 AM
asterix Allotment of Securities under Institutional Placement
2 pages 96.4KB
04/05/2020
9:32 AM
asterix Proposed issue of Securities - OSL
10 pages 40.2KB
04/05/2020
9:31 AM
  Letter to ineligible shareholders
2 pages 120.3KB
04/05/2020
9:30 AM
  Cleansing notice
3 pages 380.3KB
04/05/2020
9:29 AM
asterix Investor Presentation
37 pages 2.8MB
04/05/2020
9:28 AM
asterix OncoSil launches Capital Raising
5 pages 462.1KB
04/05/2020
9:04 AM
  OncoSil to present at Virtual Health Conference
2 pages 205.3KB
04/05/2020
9:03 AM
asterix OncoSil submits for ASEAN and APAC approvals
2 pages 217.1KB
04/05/2020
9:02 AM
  OncoSil appoints Nigel Lange as EMEA President
3 pages 449.3KB
30/04/2020
5:09 PM
asterix Appendix 4C - quarterly
9 pages 487.6KB
29/04/2020
9:15 AM
asterix Trading Halt
2 pages 211.9KB
16/04/2020
3:50 PM
  Shares forfeited and cancelled
4 pages 200.6KB
07/04/2020
8:07 AM
  Ceasing to be a substantial holder
4 pages 185.4KB
01/04/2020
8:29 AM
asterix Oncosil breakthrough device receives CE Marking approval
5 pages 229.7KB
31/03/2020
6:05 PM
  Appointment of CFO and Company Secretary
2 pages 139.4KB
27/03/2020
1:49 PM
asterix Clarification Statement
2 pages 141.5KB
27/03/2020
12:56 PM
asterix Pause in Trading
1 page 110.3KB
27/03/2020
9:15 AM
  Appendix 2A
28 pages 481.4KB
25/03/2020
6:45 PM
  Appendix 2A
28 pages 485.7KB
18/03/2020
9:24 AM
  Becoming and changing substantial holding
11 pages 491.3KB
18/03/2020
8:48 AM
asterix FDA Grants Breakthrough Device Designation
4 pages 190.9KB
11/03/2020
10:49 AM
  Change of Director's Interest Notice
2 pages 587.3KB
27/02/2020
8:26 AM
asterix Half Yearly Report and Accounts
22 pages 461.4KB
21/02/2020
4:46 PM
  Ceasing to be a substantial holder
2 pages 89.1KB
18/02/2020
5:13 PM
  Change in substantial holding
2 pages 137.1KB
30/01/2020
8:55 AM
asterix Appendix 4C - quarterly
8 pages 319.8KB
24/01/2020
2:29 PM
  Change in substantial holding
6 pages 422.8KB

Useful Information

Previous codes used by this company

  • NDL changed to OSL

Didn't find the announcement you were after? Search again.

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.